Observation of Plasmakinetic Resection of Prostate in the Treatment of Prostatic Hyperplasia

Objective To investigate the clinical effect and safety of plasmakinetic resection of prostate in the treatment of prostatic hyperplasia. Methods The clinical data of 72 patients with benign prostatic hyperplasia was retrospectively analyzed. According to the treatment methods, they were divided into the TURP group and the PKRP group, with 36 cases in each group. They were taken with transurethral bipolar plasma the resection (PKRP) and transurethral resection (TURP) for treatment. The clinical efficacy, surgery situation as well as the occurrence of complications of the two groups was observed. Results The preoperative IPSS, QOL, Qmax had no significant difference, and the postoperative IPSS, QOL scores were significantly lower after 6 months of treatment, and those of PKRP group were significantly lower than the TURP group. Compared with the preoperative surgery, the Qmax significantly increased and Qmax of PKRP group was significantly higher than that in the TURP group, P 0.05. The operation time of PKRP group and flushing time after surgery were significantly shorter than the TURP group. The postoperative hemoglobin in the PKRP group was significantly higher than that of the control group, P 0.05. The postoperative indwelling catheter time had no significant difference, P 0.05. The postoperative secondary complications in the TURP group was 19.44%, significantly higher than 8.33% of the control group (P 0.05). The major concurrent symptoms were capsule perforation, bleeding and urethral stricture. Conclusion The clinical efficacy of plasmakinetic resection of the prostate (PKRP) in the treatment of prostatic hyperplasia is significant, and it is with lower complication rate.